Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- West Conshohocken, Pennsylvania
- Most recent report
- 8-K, filed Aug 12, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 1157601
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 69
News 8 of 167
Prospectuses and Registrations 8 of 56
- S-8 Registration statement for an employee plan Jun 17, 2026
- S-8 Registration statement for an employee plan Sep 11, 2025
- S-8 Registration statement for an employee plan Jun 20, 2025
- S-8 Registration statement for an employee plan Oct 31, 2024
- 424B3 Prospectus supplement for an offering May 7, 2024
- 424B5 Prospectus supplement for an offering May 7, 2024
- S-3ASR Automatic shelf registration May 7, 2024
- 424B5 Prospectus supplement for an offering Mar 20, 2024
Proxies 8 of 35
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material May 1, 2023
- DEF 14A Proxy statement for a shareholder vote May 1, 2023
Ownership 8 of 639
- 144 Notice of a proposed sale of restricted stock Sep 28, 2026
- 4 Insider reported a trade Sep 11, 2026
- 144 Notice of a proposed sale of restricted stock Sep 11, 2026
- 144 Notice of a proposed sale of restricted stock Sep 9, 2026
- 4 Insider reported a trade Aug 20, 2026
- 144 Notice of a proposed sale of restricted stock Aug 20, 2026
- 4 Insider reported a trade Aug 18, 2026
- 3 Insider reported their initial holding Aug 18, 2026
Other 8 of 34
- ARS Annual report sent to shareholders Apr 28, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- ARS Annual report sent to shareholders Apr 29, 2024
- UPLOAD Comment letter from SEC staff Jan 25, 2024
- CORRESP Reply to SEC staff Jan 17, 2024
- UPLOAD Comment letter from SEC staff Jan 3, 2024
- CORRESP Reply to SEC staff Dec 14, 2023
- CORRESP Reply to SEC staff Dec 8, 2023
Everything here comes from Madrigal Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.